Emma Kruger

Emma Kruger

Auto-generated profile, based on publicly available information

Emma Kruger

Department of Dermatology, University of Cape Town, Cape Town, South Africa

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2025 in Allergy
Verified
Journal Article
Open access
CDCascia Day
Cascia Day
MDMimi Deetlefs
Mimi Deetlefs
LMLovemore Mapahla
Lovemore Mapahla
YJYejin Jang
Yejin Jang
QGQiqa Gusha‐Mhlekude
Qiqa Gusha‐Mhlekude
JPJonny Peter
Jonny Peter

1 December 2022 in South African Journal of Surgery
Verified
Journal Article
Open access
PDF file
EKE Kruger
E Kruger
EGE Georgiou
E Georgiou
This report describes acute gallbladder torsion in a previously healthy 16-year-old male. The patient presented with acute right-sided abdominal pain in keeping with acute appendicitis and was taken for a diagnostic laparoscopy where an intraoperative diagnosis of gallbladder torsion was made. This case highlights a very rare surgical presentation in an uncommon patient profile. It highlights the benefit of diagnostic laparoscopy in a resource-constrained facility.

1 July 2020 in Journal of Pediatric Surgery Case Reports
Verified
Journal Article
Open access
EKEmma Kruger
Emma Kruger
POPatience Odeniyide
Patience Odeniyide
EDEmily Dunn
Emily Dunn
JLJeffrey Lukish
Jeffrey Lukish
LGLindsay Goicochea
Lindsay Goicochea
DRDaniel S. Rhee
Daniel S. Rhee

29 September 2026 in Current Treatment Options in Allergy
Verified
Journal Article
Open access
PDF file
MAMelissa Afshar-Bakshloo
Melissa Afshar-Bakshloo
LBLena Marie Böhm
Lena Marie Böhm
EKEmma Kruger
Emma Kruger
LBLaís Ferreira Lopes Brum
Laís Ferreira Lopes Brum
AJAtakan Jordan
Atakan Jordan
HBHanna Bonnekoh
Hanna Bonnekoh
Purpose of Review: This review aims to provide an overview and update on the current knowledge of acute (spontaneous) urticaria (AU) and chronic spontaneous urticaria (CSU), the underlying mechanisms that drive AU progression to CSU and remission, and characterize the existing knowledge gap. A summary of current and prospective treatment options serves to guide treatment decisions. Recent Findings: Cutaneous mast cells (MC) are known as central effector cells in AU and CSU pathogenesis. In CSU, the two established endotypes, type I “autoallergy”, defined by the production of IgE antibodies against autoantigens, and type IIb “autoimmunity”, characterized by the production of functional IgG autoantibodies targeting IgE or FcεRI on MCs, have contributed crucially to pathophysiological understanding. Currently, total IgE and IgG anti-TPO antibodies are the only biomarkers available, which are used in clinical practice to guide treatment decisions. With the characterization of Bruton’s tyrosine kinase, an intracellular signaling molecule, and Mas-related G protein-coupled receptor member X2, an IgE-independent activating receptor that represents a link between MCs and sensory nerve endings, novel insights in pathophysiology and promising potential treatment targets have been gained. Summary: The upstream mechanisms leading to MC activation in AU, the processes mediating either progression from AU to CSU or early resolution of AU, as well as the question of what drives remission in CSU remain largely unresolved. Ongoing research aims at identifying predictors of disease courses, characterizing mechanisms in non-autoallergic/autoimmune CSU, and establishing biomarkers for early risk stratification and personalized therapy.